Welcome to our dedicated page for VENDOME ACQUISITION I news (Ticker: VNMEU), a resource for investors and traders seeking the latest updates and insights on VENDOME ACQUISITION I stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VENDOME ACQUISITION I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VENDOME ACQUISITION I's position in the market.
Vendome Acquisition Corporation I (Nasdaq:VNMEU) announced that starting August 22, 2025, holders of its Units can separately trade Class A ordinary shares and warrants. The separated securities will trade on Nasdaq under symbols "VNME" (ordinary shares) and "VNMEW" (warrants), while unseparated Units will continue trading as "VNMEU".
The SPAC aims to pursue business combinations in the consumer sector, focusing on targets in North America, Southeast Asia, and Europe. D. Boral Capital LLC served as the sole book-running manager for the initial public offering. The company's registration statement was declared effective by the SEC on June 30, 2025.
FAQ
What is the current stock price of VENDOME ACQUISITION I (VNMEU)?
